Pharma

Nov 30 2017

Omni Bio Pharmaceutical Appoints Dr #juice #pharma

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …

Oct 4 2017

Omni Bio Pharmaceutical Appoints Dr #zuellig #pharma

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …

Jul 9 2017

Omni Bio Pharmaceutical Appoints Dr #cadence #pharma

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …

May 29 2017

Omni Bio Pharmaceutical Appoints Dr #generic #pharmaceuticals

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …

May 14 2017

Omni Bio Pharmaceutical Appoints Dr #pharmaceutical #company #names

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …

Apr 19 2017

Omni Bio Pharmaceutical Appoints Dr #healthcare #news

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …

Apr 9 2017

Omni Bio Pharmaceutical Appoints Dr #hi #tech #pharma

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …

Mar 18 2017

Omni Bio Pharmaceutical Appoints Dr #pharma #consulting #companies

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …

Nov 21 2016

Omni Bio Pharmaceutical Appoints Dr #future #of #pharmaceutical #industry

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …

Oct 27 2016

Omni Bio Pharmaceutical Appoints Dr #pharma #clinical #trials

#forrest pharma # May 01, 2014 09:00 ET Omni Bio Pharmaceutical Appoints Dr. Bruce Forrest to Chief Development Officer Role DENVER, CO–(Marketwired – May 1, 2014) – Omni Bio Pharmaceutical, Inc. (“Omni Bio”) ( OTCQB. OMBP ), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of indications and the development of next-generation recombinant forms of AAT, today announced the appointment of Dr. Bruce D. Forrest to the position of Chief Development Officer. Dr. Forrest is currently President of B D Forrest Company, Inc. a biopharmaceutical consulting firm that …